HL7 Europe Base and Core FHIR IG
2.0.0 - trial-use 150

This page is part of the HL7 Europe Base and Core (v2.0.0: STU 2) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Immunization: Immunization Example

status: Completed

vaccineCode: SARS-CoV-2 mRNA vaccine

Manufacturers

-Reference
*Example Vaccine Manufacturer

lotNumber: CVD2024B04

patient: John Doe Male, DoB: 1980-01-01

occurrence: 2024-10-05

primarySource: true

location: Location Best Location

site: Left upper arm structure

route: Intramuscular route

Performers

-FunctionActor
*Administering ProviderPractitionerRole General practice (specialty)

Reasons

-Concept
*Disease caused by severe acute respiratory syndrome coronavirus 2 (disorder)

ProtocolApplieds

-TargetDiseaseDoseNumberSeriesDoses
*COVID-1922